PC-2021-08 - Laserfiche WebLink

DocuSign Envelope ID:A27BEFEB-8670-4027-B7B4-DA684D5884EB Resolution No. PC-2021-08 Page Two including: encouraging the reuse of vacant and underutilized parcels and buildings within existing urban areas; requiring higher residential and commercial densities in the proximity of transportation corridors and hubs; assuring that new major commercial, office, and institutional centers are adequately served by transit and by pedestrian and bicycle facilities; maintaining a complete well-rounded community of desirable neighborhoods, a strong employment base, and a variety of community facilities; and zoning sufficient land for neighborhood, community, and regional commercial uses to support Pleasanton's increasing business activity. Section 2: This resolution shall become effective immediately upon its passage and adoption. PASSED, APPROVED AND ADOPTED by the Planning Commission of the City of Pleasanton at a regular meeting held on May 26, 2021, by the following vote: Ayes: Commissioners Allen, Brown, Gaidos, Nibert, Pace Noes: None Absent: None Abstain: None ATTEST: rowDocuSigned by: n, 1aE7WDGPEGd2S Melinda encs Justin Brown Secretary, Planning Commission Chair APPROVED AS TO FORM: Larissa Seto Assistant City Attorney y; and WHEREAS, 10x Genomics has applied to the City for a development agreement concerning the Project; and WHEREAS, at its duly noticed public meeting of May 26, 2021, the Planning Commission considered the written agenda report, all public testimony, relevant exhibits, and staff recommendations; and WHEREAS, at its duly noticed public meeting of May 26, 2021, the Planning Commission determined the Development Agreement is consistent with the City's General Plan. NOW, THEREFORE BE IT RESOLVED by the Planning Commission of the City of Pleasanton, based on the entire record of proceedings, including the oral and written agenda reports and all public comment and testimony: Section 1: Recommends the City Council find the proposed Project's Development Agreement is consistent with the City's General Plan based on the following: The Land Use Designation at 1701 Springdale Avenue, Pleasanton is "Retail/Highway/Service Commercial; Business and Professional Offices", which permits office uses. R&D and laboratory uses are not separately defined or identified as a land use category in the PMC; however, both are listed among a broad range of potential uses in the PMC's definition of"Light Industrial." R&D and laboratory uses are not expressly permitted in the C-R (p) District; thus, the Project would be consistent with the General Plan Land Use Designation if the subject site is rezoned to PUD. The proposed 381,000 sq. ft. of building area would result in a floor area ratio (FAR) of 60% for the subject site. This complies with the 60% maximum FAR permitted for the designated land use. The proposed Project would further several General Plan Goals, Programs, and Policies,